Physician profile
Berkay Basagaoglu
NPI 1326677477
$4,458.95
in general payments reported to CMS, 2019-2025
9 companies · $1,347 in 2025
The $1,347 reported for 2025 was more than what 91% of providers received nationally.
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $157 · 2023: $123 · 2024: $2,831 · 2025: $1,347.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,880 · Travel and Lodging: $1,422.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,879.88 |
| Travel and Lodging | $1,421.66 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $3,458.89 | 2023-2025 | Natrelle Saline-Filled Breast Implants |
| Polynovo North America LLC | $356.63 | 2024-2025 | Novosorb Btm |
| Stryker Corporation | $170.95 | 2022-2025 | Na, Spy-Phi System |
| Endo USA, INC. | $136.40 | 2025 | Xiaflex |
| Depuy Synthes Sales INC. | $122.23 | 2024 | Matrixmandible |
| Davol INC. | $70.54 | 2022 | |
| Motiva USA, LLC | $65.12 | 2025 | |
| Integra Lifesciences Corporation | $57.54 | 2022 | |
| Kci USA, INC. | $20.65 | 2023 | Snap, V.A.C. Veraflo, 3m Cavilon |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Berkay Basagaoglu listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.